Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial

BackgroundBioresorbable vascular scaffolds (BVSs) have been developed as a potential solution to mitigate late complications associated with drug-eluting metallic stents (DESs) in percutaneous coronary intervention for coronary artery disease. While numerous studies have compared BVSs to DESs, none...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Samir Bengueddache, Malica Cook, Sonja Lehmann, Diego Arroyo, Mario Togni, Serban Puricel, Stephane Cook
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2024-09-01
Seri Bilgileri:	Frontiers in Cardiovascular Medicine
Konular:	percutaneous coronary intervention (PCI) drug-eluting stent (DES) bioresorbable vascular scaffold (BVS) randomized clinical trial coronary artery disease
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1426348/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!